logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Craig Underhill

Geelong Hospital
H指数:40
被引数:7,366

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia

与澳大利亚接受氟嘧啶类抗肿瘤治疗患者的标准治疗方案相比，DPYD基因分型的成本效益分析。

Clinical Drug Investigation
IF2.7
2025-10-270
OA
Sarah Glewis; Mussab Fagery; Senthil Lingaratnam; Sam Harris; Chloe Georgiou; Craig Underhill; Mark Warren; Robert Campbell; Jennifer H. Martin; Jeanne Tie; Maarten IJzerman; Marliese Alexander; Michael Michael
EP.17.02 Treatment and Survival Outcomes for Indigenous Australians Within the Victorian Lung Cancer Registry

EP.17.02 维多利亚肺癌登记系统中的原住民澳大利亚人治疗与生存结局

Journal of Thoracic Oncology
IF20.8
2025-10-230
PRE
M. Wong; J. Zeng; S. Tissera; M. Lloyd; L. Briggs; J. Lesage; T. Wood; K. Griffiths; J. Clark; J. Gillies; W. Faisal; J. Torres; R. Blum; C. Underhill; M. Caldecott; G. Richardson; M. Alexander; T. John; J. Bartlett; L. Irving; K. See; P. Parente; S. Parakh; D. Langton; C. Lyne; E. Samuel; G. Adabi; M. Moore; M. Conron; G. Wright; N. Zeps; N. Atkin; Z. McQuilten; S. Harden; J. Zalcberg; R. Stirling
Impact of Stage-Specific Guideline Concordant Treatment in Small Cell Lung Cancer in Victoria, Australia

澳大利亚维多利亚州小细胞肺癌中与分期特异性指南一致的规范治疗的影响

THORACIC CANCER
IF2.3
2025-09-110
OAAI
Tissera, Sanuki; Billah, Baki; Karim, Md Nazmul; Antippa, Phillip; Blum, Robert; Caldecott, Michelle; Conron, Matthew; Olesen, Inger; Parente, Phil; Richardson, Gary; Samuel, Evangeline; See, Katharine; Underhill, Craig; Wright, Gavin; Torres, Javier; Parakh, Sagun; John, Tom; Zalcberg, John; Faisal, Wasek; Harden, Susan; Stirling, Rob G.
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation

Garsorasib，一种KRAS G12C抑制剂，有或没有西妥昔单抗，一种EGFR抗体，在患有KRAS G12C突变的晚期实体瘤的II期临床试验的结直肠癌队列中

Signal Transduction and Targeted Therapy
IF52.7
2025-06-170
OA
Dan-Yun Ruan; Hao-Xiang Wu; Ye Xu; Pamela N. Munster; Yanhong Deng; Gary Richardson; Dong Yan; Myung-Ah Lee; Keun-Wook Lee; Hongming Pan; Steven Hager; Xingya Li; Shaozhong Wei; Xinfang Hou; Craig Underhill; Michael Millward; Ina Nordman; Jingdong Zhang; Jianzhen Shan; Guohong Han; Jaspreet Grewal; Shirish M. Gadgeel; Rachel E. Sanborn; Seok Jae Huh; Xiaohua Hu; Yihong Zhang; Ziyong Xiang; Laisheng Luo; Xiaoxi Xie; Zhe Shi; Yaolin Wang; Ling Zhang; Feng Wang; Rui-Hua Xu
Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer Registry

临床肿瘤登记处对肺癌质量指标的影响：维多利亚肺癌登记处的回顾性观察研究

Clinical Oncology
IF3
2025-05-260
OA
R.G. Stirling; U. Samankula; M. Lloyd; M. Brand; L. Briggs; J. Lesage; T. Wood; C. Underhill; S. Parakh; W. Faisal; R. Blum; G. Richardson; P. Parente; M. Caldecott; I. Olesen; J. Torres; E. Samuel; B. Jennings; K. See; D. Langton; J. Zalcberg
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
2025-03-010
OAAI
Alexander, Marliese; Lim, Chiao Xin; Lingaratnam, Senthil; Glewis, Sarah; Wickens, Joanne; Hird, Abbey; Chen, Zi Yue; Bozkurt, Alistair; Khot, Amit; Routledge, David; Harris, Sam; Underhill, Craig; Whitechurch, Ashley; Leong, Lydia; Pergolini, Marcus; Rowan, Gail; Samo, Monnette; Georgiou, Chloe; Savas, Peter; Devine, Jenny; Kepert, Alysia; Hussainy, Safeera Y.
A multi-centre analysis of metastatic colorectal cancer diagnosed under the age of 35: A molecularly distinct group?

35岁以下诊断的转移性结直肠癌的多中心分析：一个分子上独特的群体？

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Williams, C.; Jalali, A.; Ackland, S. P.; Burge, M.; Caird, S.; Hayes, T.; Kim, G.; Lee, B.; Nott, L. M.; Ma, B. B. Y.; Mendis, S.; McLachlan, S-A.; Potasz, N.; Rainey, N.; Shapiro, J.; Underhill, C. R.; Wong, R.; Wong, S. F.; Wong, V.; Gibbs, P.
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
2024-11-290
PRE
Glewis, Sarah; Lingaratnam, Senthil; Lee, Benjamin; Campbell, Ian; Ijzerman, Maarten; Fagery, Mussab; Harris, Sam; Georgiou, Chloe; Underhill, Craig; Warren, Mark; Campbell, Robert; Jayawardana, Madawa; Silva, S. Sandun M.; Martin, Jennifer H.; Tie, Jeanne; Alexander, Marliese; Michael, Michael
Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT study

纳武利尤单抗和伊匹木单抗联合治疗晚期dMMR/MSI-H非结直肠癌：MoST-CIRCUIT II期研究的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Klein, O.; Gao, B.; Chan, H.; Michael, M.; Zielinski, R.; So, J.; Harris, S. J.; Kee, D.; Collins, I. M.; Lam, W-S.; Lyle, M.; Underhill, C. R.; Brown, M.; Harrup, R. A.; Wong, S. F.; Palmer, J. B.; Thomas, D.; Wilkie, K.; Cebon, J.; Carlino, M. S.
Phase II trial of vemurafenib (VEM) and cobimetinib (COB) in BRAF V600-mutated solid tumours and first-line (1L) non-small cell lung cancer (NSCLC): Australian molecular screening and therapeutics (MoST) substudy 12

vemurafenib（VEM）和cobimetinib（COB）在BRAF V600突变实体瘤和一线（1L）非小细胞肺癌（NSCLC）中的II期试验：澳大利亚分子筛查和治疗（MoST）子研究12

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lin, F. P.; Mersiades, A.; Lee, J.; Xu, W.; Chinchen, S.; Charakidis, M.; Thavaneswaran, S.; Hughes, B. G. M.; Underhill, C. R.; Takhar, H. S.; Harrup, R.; Nagrial, A.; Millward, M.; Desai, J.; Espinoza, D.; Lee, C. K.; Solomon, B. J.; Simes, J.; Pavlakis, N.; Thomas, D.
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
JOURNAL OF NEURO-ONCOLOGY
IF3.1
2024-04-171
PRE
Gately, Lucy; Mesia, C.; Sepulveda, J. M.; del Barco, S.; Pineda, E.; Girones, R.; Fuster, J.; Dumas, M.; Gill, S.; Navarro, L. M.; Herrero, A.; Dowling, A.; de las Penas, R.; Vaz, M. A.; Alonso, M.; Lwin, Z.; Harrup, R.; Peralta, S.; Long, A.; Perez-Segura, P.; Ahern, E.; Garate, C. O.; Wong, M.; Campbell, R.; Cuff, K.; Jennens, R.; Gallego, O.; Underhill, C.; Martinez-Garcia, M.; Covela, M.; Cooper, A.; Brown, S.; Rosenthal, M.; Torres, J.; Collins, I. M.; Gibbs, P.; Balana, C.
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)

对两项前瞻性随机研究的综合分析，探讨延长放疗后替莫唑胺对新诊断胶质母细胞瘤生存结局的影响 (12月，10.1007/s11060-023-04513-1，2023)

JOURNAL OF NEURO-ONCOLOGY
IF3.1
2024-01-301
OA
Gately, L.; Mesia, C.; Sepulveda, J. M.; del Barco, S.; Pineda, E.; Girones, R.; Fuster, J.; Hong, W.; Dumas, M.; Gill, S.; Navarro, L. M.; Herrero, A.; Dowling, A.; de las Penas, R.; Vaz, M. A.; Alonso, M.; Lwin, Z.; Harrup, R.; Peralta, S.; Long, A.; Perez-Segura, P.; Ahern, E.; Garate, C. O.; Wong, M.; Campbell, R.; Cuff, K.; Jennens, R.; Gallego, O.; Underhill, C.; Martinez-Garcia, M.; Covela, M.; Cooper, A.; Brown, S.; Rosenthal, M.; Torres, J.; Collins, I. M.; Gibbs, P.; Balana, C.
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
JOURNAL OF NEURO-ONCOLOGY
IF3.1
2023-12-283
PRE
Gately, L.; Mesia, C.; Sepulveda, J. M.; del Barco, S.; Pineda, E.; Girones, R.; Fuster, J.; Hong, W.; Dumas, M.; Gill, S.; Navarro, L. M.; Herrero, A.; Dowling, A.; de las Penas, R.; Vaz, M. A.; Alonso, M.; Lwin, Z.; Harrup, R.; Peralta, S.; Long, A.; Perez-Segura, P.; Ahern, E.; Garate, C. O.; Wong, M.; Campbell, R.; Cuff, K.; Jennens, R.; Gallego, O.; Underhill, C.; Martinez-Garcia, M.; Covela, M.; Cooper, A.; Brown, S.; Rosenthal, M.; Torres, J.; Collins, I. M.; Gibbs, P.; Balana, C.

研究方向

暂未获取到该数据
J
Javier Torres
H 指数:11论文数:121被引数:677
R
Rosemary Harrup
H 指数:20论文数:157被引数:2,380
E
Eva Segelov
H 指数:35论文数:324被引数:4,660
D
Damien Kee
H 指数:24论文数:103被引数:4,735
M
Marliese Alexander
H 指数:21论文数:156被引数:1,437
J
Jonathan Cebon
H 指数:88论文数:570被引数:4.4万
M
Michael Michael
H 指数:44论文数:303被引数:7,076
S
Sam Harris
H 指数:11论文数:38被引数:1,358
L
Louise Nott
H 指数:20论文数:122被引数:2,950
I
Ian Collins
H 指数:18论文数:133被引数:1,013